MIRA
INFORM REPORT
|
Report Date : |
30.10.2007 |
IDENTIFICATION
DETAILS
|
Name : |
MARVEL LIFE SCIENCES LIMITED |
|
|
|
|
Registered Office : |
3 Brook Business Cntr, Cowley Mill Rd, Uxbridge, Middx UB8
2FX |
|
|
|
|
Country : |
United Kingdom |
|
|
|
|
Financials (as on) : |
31.03.2006 |
|
|
|
|
Date of Incorporation : |
19/05/1999 |
|
|
|
|
Com. Reg. No.: |
03773938 |
|
|
|
|
Legal Form : |
Private Limited Liability Company (GB) |
|
|
|
|
Line of Business : |
Import and export of pharmaceutical products. |
RATING &
COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
Company Identification Details
|
|
|
|
Subject Reported on |
MARVEL LIFE SCIENCES LIMITED |
|
Trading Address |
Raebarn House,100 Northolt Road,HARROW,HA2 0YJ |
|
|
|
|
|
|
|
|
This company exhibits characteristics similar to companies
who have generally failed although they tend to be less severe. e.g. negative
capital employed and / or large trading loss |
Official Company Data
|
|
|
|
Legal Form |
Private Limited Liability Company (GB) |
|
Registration Number |
03773938 |
|
Date of Incorporation |
19/05/1999 |
|
Registered Office |
3 Brook Business Cntr, Cowley Mill Rd, Uxbridge, Middx UB8
2FX |
|
Date of Last Annual Return to Registry |
19/05/2007 |
|
Activities |
Import and export of pharmaceutical products |
|
Accounts |
The last filed accounts cover the period to 31/03/2006 and
were filed on 11/07/2007 |
Recently Filed Documents
Details of the most recent documents
|
Date
Received |
Description |
|
19/05/2007 |
Annual Return |
|
31/03/2006 |
Financial Statement / Set of Accounts |
|
It should be noted that there is no legal requirement to
file satisfaction details of mortgages/charges at Companies House. |
Known Directors
|
|
|
||
|
DIRECTOR |
|
||
|
Occupation |
IMPORT/EXPORT |
||
|
Address |
18, LOWER ROAD , HARROW , MIDDX
, HA2 0DA |
||
|
Country of Origin |
BRITISH |
||
|
Date of Birth |
19/11/1936 |
||
|
Appointment Date |
27/05/1999 |
||
|
Other Appointments |
M.J. EXPORTS (UK) LIMITED, MARVEL CHEMICALS
LIMITED, MARVEL LIFE SCIENCES LIMITED, MARVEL-BECKETT RESEARCH LTD |
||
|
DIRECTOR |
|
||
|
Occupation |
TRADING |
||
|
Address |
7, PENKETH DRIVE , HARROW , MIDDX
, HA1 3JX |
||
|
Country of Origin |
BRITISH |
||
|
Date of Birth |
09/04/1962 |
||
|
Appointment Date |
27/05/1999 |
||
|
Other Appointments |
MARVEL LIFE SCIENCES LIMITED, MARVEL-BECKETT RESEARCH
LTD |
||
|
DIRECTOR |
|
||
|
Occupation |
MEDICAL DOCTOR |
||
|
Address |
, AKADEMIKA ANOKHINA ST 9 , FLAT NO 32 MOSCOW
, RUSSIA , |
||
|
Country of Origin |
INDIAN |
||
|
Date of Birth |
05/04/1963 |
||
|
Appointment Date |
21/02/2000 |
||
|
Other Appointments |
MARVEL LIFE SCIENCES LIMITED |
||
|
SECRETARY |
YOGENKUMAR ACHARYA |
||
|
Address |
38 CULLINGTON CLOSE, HARROW, MIDDLESEX , HA3
8LY , HA3 8LY |
||
|
Country of Origin |
BRITISH |
||
|
Date of Birth |
31/07/1952 |
||
|
Appointment Date |
31/10/2005 |
Recently Resigned Directors (last
3)
|
None |
Share Summary
|
|
|||||||||
|
Shareholder Name |
Percentage |
|
|
|
|
|
|
|
|
|
Marvel Overseas Investments Ltd |
40.00% |
|
|
|
|
|
|
|
|
|
M J Exports (U K) Ltd |
33.00% |
|
|
|
|
|
|
|
|
|
Anglo Gulf Agro Chemicals Ltd |
27.00% |
|
|
|
|
|
|
|
|
Mortgages and Charges
|
|
|
|
Total Registered |
1 |
|
Total Outstanding |
1 |
|
Total Satisfied |
0 |
|
Most Recent Mortgage |
08/04/2002 |
|
|
|
|
|
|
|
Date Registered |
10/04/2002 |
|
Type |
395 |
|
Date Created |
08/04/2002 |
|
Lender |
HSBC BANK PLC |
|
Secured On |
ALL MONIES DUE OR TO BECOME DUE FROM THE COMPANY TO THE
CHARGEE ON ANY ACCOUNT WHATSOEVER |
|
Details |
FIXED AND FLOATING CHARGES OVER THE UNDERTAKING AND ALL
PROPERTY AND ASSETS PRESENT AND FUTURE INCLUDING GOODWILL BOOKDEBTS UNCALLED
CAPITAL BUILDINGS FIXTURES FIXED PLANT AND MACHINERY |
|
Satisfied? |
No |
Public Record Information
Summary of CCJ's/Scottish Decrees
|
There are no unsatisfied CCJs against the company. |
Operations
|
|
|
|
Activities |
Import and export of pharmaceutical products |
|
Sic Code |
Description |
|
7484 |
Other business activities not elsewhere classified |
|
Staff Employed |
1 |
|
Auditors |
Barnes Roffe LLP |
|
Auditors Notes |
No Qualification. The Auditors have expressed a clean
opinion (i.e. unqualified with no referrals) on the latest accounts. |
Financial Data
|
The following figures are shown in units of 000 |
|
Profit and Loss |
|
Number of Weeks |
52 |
52 |
52 |
52 |
|
Accounts Date |
31/03/2006 |
31/03/2005 |
31/03/2004 |
31/03/2003 |
|
Currency |
GBP |
GBP |
GBP |
GBP |
|
Consolidated? |
No |
No |
No |
No |
|
SALES |
3,968 |
2,254 |
4,359 |
960 |
|
Export Sales |
3,968 |
2,254 |
- |
- |
|
Cost of goods sold |
3,691 |
2,105 |
4,219 |
815 |
|
GROSS PROFIT |
277 |
149 |
141 |
146 |
|
General administration costs (-) |
268 |
170 |
118 |
138 |
|
Wages and Salaries |
46 |
44 |
42 |
37 |
|
Depreciation |
0 |
0 |
0 |
0 |
|
Net Operating Profit(Loss) |
9 |
-21 |
22 |
8 |
|
Group Non Trading Income |
0 |
- |
- |
- |
|
Total Non Trading Income |
0 |
0 |
1 |
0 |
|
Interest expenses & similar (-) |
2 |
23 |
10 |
4 |
|
Other financial charges |
105 |
- |
- |
- |
|
Financial Expenses |
108 |
23 |
10 |
4 |
|
PRE TAX PROFIT |
-98 |
-44 |
13 |
3 |
|
PROFIT AFTER TAX |
-98 |
-44 |
13 |
3 |
|
Net Loss |
98 |
44 |
- |
- |
|
Dividends Payable |
0 |
0 |
0 |
0 |
|
RETAINED PROFITS |
- |
- |
13 |
3 |
|
Balance Sheet |
|
Number of Weeks |
52 |
52 |
52 |
52 |
|
Accounts Date |
31/03/2006 |
31/03/2005 |
31/03/2004 |
31/03/2003 |
|
Currency |
GBP |
GBP |
GBP |
GBP |
|
Consolidated? |
No |
No |
No |
No |
|
TOTAL FIXED ASSETS |
130 |
172 |
12 |
12 |
|
Total Fixed Assets |
2 |
- |
- |
- |
|
Intermediate Assets |
10 |
10 |
10 |
10 |
|
Intangible Assets |
118 |
160 |
- |
- |
|
TOTAL CURRENT ASSETS |
2,193 |
2,081 |
1,946 |
969 |
|
Trade Debtors |
736 |
624 |
994 |
650 |
|
Other Receivables |
450 |
297 |
466 |
286 |
|
Group Loans |
1,003 |
843 |
369 |
- |
|
Cash |
3 |
317 |
2 |
2 |
|
TOTAL ASSETS |
2,323 |
2,254 |
1,958 |
981 |
|
TOTAL CURRENT LIABILITIES |
2,418 |
2,251 |
1,912 |
948 |
|
Trade Creditors |
1,386 |
1,373 |
1,350 |
309 |
|
Bank Overdraft |
159 |
168 |
214 |
492 |
|
Taxes |
1 |
- |
- |
- |
|
Other Current Liabilities |
871 |
711 |
347 |
147 |
|
WORKING CAPITAL |
-225 |
-170 |
35 |
21 |
|
TOTAL LONG TERM LIABS |
0 |
0 |
0 |
0 |
|
NET ASSETS/(LIABILITIES) |
-95 |
3 |
47 |
34 |
|
SHARE CAPITAL + RESERVES |
-95 |
3 |
47 |
34 |
|
Issued Share Capital |
75 |
75 |
75 |
75 |
|
Profit and Loss account |
-170 |
-72 |
-28 |
-41 |
|
SHAREHOLDERS FUNDS |
-95 |
3 |
47 |
34 |
|
CAPITAL EMPLOYED |
-95 |
3 |
47 |
34 |
|
TANGIBLE NET WORTH |
-213 |
-157 |
47 |
34 |
Key Credit Ratios
|
Accounts Date |
31/03/2006 |
31/03/2005 |
31/03/2004 |
31/03/2003 |
|
Current Ratio |
0.91 |
0.92 |
1.02 |
1.02 |
|
Profit Before Tax |
-0.02 |
-0.02 |
0.00 |
0.00 |
|
Creditors Days (D.P.O) |
137.06 |
238.07 |
116.82 |
138.56 |
|
Quick Ratio |
- |
- |
0.96 |
0.99 |
|
Return on Assets |
-4.46 |
-2.11 |
0.67 |
0.31 |
|
T.N.W/Total Assets |
-0.09 |
-0.07 |
0.02 |
0.03 |
|
Return on Capital |
103.16 |
-1466.67 |
27.66 |
8.82 |
|
Working Capital/Sales |
0.00 |
0.00 |
0.00 |
0.00 |
|
Stock Turnover |
0.00 |
0.00 |
0.00 |
0.00 |
Financial Summary
|
Turnover |
Turnover increased by more than 76% in the period.
Turnover totaled GBP 3,968,000 for the period. |
|
Operating Profit |
Totaled GBP 9,000 In the period prior a loss of GBP
21,000 was achieved. |
|
Pre Tax |
The subject made a loss of GBP 98,000 compared with
a loss of GBP 44,000 in the previous period. |
|
Working Capital |
The company's working capital deficiency increased in the
period and now stands at GBP 225,000 |
|
Tangible Net Worth |
Net worth reduced by 56,000 during the period and now
stands at GBP -213,000 |
|
Fixed Assets |
The subjects fixed assets increased during the period by
GBP to GBP 2,000 and are now 0% of total assets compared with 0%
in the previous period |
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)